72 Investment Holdings, LLC reported 5 positions worth $49.96M for the quarter ended Jun 30, 2026, up 0.7% on the prior quarter. It opened 0 new positions, added to 0, trimmed 0 and exited 0. Its largest holding is Praxis Precision Medicines, Inc. at 44.2% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
No positions were added to this quarter.
No positions were reduced this quarter.
No new positions this quarter.
No positions were closed this quarter.
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | PRAX Praxis Precision Medicines, Inc. | Healthcare | 65.9K | $22.07M | 44.18% | 0 | 0.0% | Unchanged | 0.23% |
| 2 | ANRO Alto Neuroscience, Inc. | Healthcare | 667.8K | $17.62M | 35.27% | 0 | 0.0% | Unchanged | 1.56% |
| 3 | LENZ LENZ Therapeutics, Inc. | Healthcare | 1.02M | $5.78M | 11.57% | 0 | 0.0% | Unchanged | 3.24% |
| 4 | KRRO Korro Bio, Inc. | Healthcare | 276.8K | $3.65M | 7.3% | 0 | 0.0% | Unchanged | 1.57% |
| 5 | CRBU Caribou Biosciences, Inc. | Healthcare | 474.1K | $834.36K | 1.67% | 0 | 0.0% | Unchanged | 0.45% |
Tip. Select a row to see that position’s full history at 72 Investment Holdings.
As of its Q2 2026 13F filing, 72 Investment Holdings, LLC’s five largest positions were Praxis Precision Medicines, Inc. (PRAX) at 44.2%, Alto Neuroscience, Inc. (ANRO) at 35.3%, LENZ Therapeutics, Inc. (LENZ) at 11.6%, Korro Bio, Inc. (KRRO) at 7.3%, Caribou Biosciences, Inc. (CRBU) at 1.7% of the reported portfolio.
72 Investment Holdings, LLC reported a 13F portfolio worth $49.96M across 5 positions for Q2 2026. That is up 0.7% from the previous quarter.
From the Form 13F-HR reports 72 Investment Holdings, LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.